Top

Optie A:

Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
Optie B:

Deel de link per e-mail
Link delen

vorige hoofdstuk Tumoren van het zenuwstelsel

volgende hoofdstuk Tumoren van de oogleden, ogen en orbita

Tip

Swipe om te navigeren naar een ander hoofdstuk

2017 | OriginalPaper | Hoofdstuk

30. Endocriene tumoren

eerste hoofdstuk lezen

Auteurs: A. M. Pereira Arias, J. W. A. Smit, J. Kievit, E. Kapiteijn, P. T. A. M. Lips, C. J. Lips, H. R. Haak, E. P. M. van der Kleij-Corssmit, O. M. Dekkers, R. A. Feelders, N. R. Biermasz, W. de Herder, H. F. ten Kroode, Th. P. Links

Uitgeverij: Bohn Stafleu van Loghum

Gepubliceerd in: Leerboek oncologie

» Toegang tot de volledige tekst krijgen

Samenvatting

De endocriene oncologie betreft een uitgebreid vakgebied, waarbij behalve de endocrinologie en oncologie andere disciplines, zoals de klinische farmacologie, heelkunde, pathologie, genetica en moleculaire biologie nauw zijn betrokken. Tumoren van endocriene cellen worden symptomatisch gekenmerkt door overproductie van hormonen of door massa-effect van de tumor, bijvoorbeeld een niet-functionerende hypofysetumor. Soms zijn er weinig klachten, zoals bij metastasering van schildkliercarcinoom. Veel tumoren produceren ectopisch hormonen, waardoor specifieke klinische beelden kunnen ontstaan.

Log in om toegang te krijgen

Hier inloggen

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Academy Geneeskunde UMCU 2018-2019

Meer informatie

BSL Academy Geneeskunde Radboud 2018-2019

Meer informatie

BSL Academy Oncologische Zorg HU 2018-2019

Meer informatie

BSL - Leerboek oncologie

Meer informatie

BSL Academy Oncologische Zorg HU 2019-2020

Meer informatie

BSL Academy Geneeskunde Radboud Universiteit 2019-2020

Meer informatie

BSL Academy Geneeskunde UMC Utrecht 2019-2020

Meer informatie

BSL Academy Radboud Universiteit 2020-2021

Meer informatie

BSL Academy Geneeskunde UMC Utrecht 2020-2023

Meer informatie

BSL Academy Oncologische Zorg HU 2020-2021

Meer informatie

Almeida MQ, Stratakis CA. Carney complex and other conditions associated with micronodular adrenal hyperplasias. Best Pract Res Clin Endocrinol Metab. 2010 Dec 24;24(6):907–14. http://www.ncbi.nlm.nih.gov/pubmed/21115159. CrossRefPubMedPubMedCentral

Gimenez-Roqueplo AP, Dahia PL, Robledo M. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res. 2012;44:328–33. CrossRefPubMed

Haller F, et al. Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad. Endocr Relat Cancer 2014 May 23;21(4):567–77. CrossRefPubMedPubMedCentral

Krampitz GW, Norton JA. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Cancer 2014;120(13):1920–31. CrossRefPubMed

Maher ER, Neumann HP, Richard S. Von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet. 2011;19(6):617–23. CrossRefPubMedPubMedCentral

Mester J, Eng C. When overgrowth bumps into cancer: the PTEN-Opathies. Am J Med Genet C Semin Med Genet. 2013;163C(2):114–21. CrossRefPubMed

Minkelen R van, Bever Y van, Kromosoeto JN, Withagen-Hermans CJ, Nieuwlaat A, Halley DJ, Ouweland AM van den. A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands. Clin Genet. 2014;85(4):318–27. http://www.ncbi.nlm.nih.gov/pubmed/23656349 CrossRefPubMed

Northrup H, Krueger DA. International tuberous sclerosis complex consensus group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49(4):243–54. CrossRefPubMedPubMedCentral

Rodriguez FJ, Stratakis CA, Evans DG. Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes. Acta Neuropathol. 2012; 123: 349–67.

Staser K1, Yang FC, Clapp DW. Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression. Annu Rev Pathol. 2012;7:469–95.

Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML, Endocrine society, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97(9):2990–3011. http://www.ncbi.nlm.nih.gov/pubmed/22723327.

Wadt KA, Gerdes AM, Hansen TV, Toft BG, Friis-Hansen L, Andersen MK. Novel germline c-MET mutation in a family with hereditary papillary renal carcinoma. Fam Cancer 2012;11(3):535–7. CrossRefPubMed

Wang O, Wang C, Nie M, Cui Q, Guan H, Jiang Y, Li M, Xia W, Meng X, Xing X. Novel HRPT2/CDC73 gene mutations and loss of expression of parafibromin in Chinese patients with clinically sporadic parathyroid carcinomas. PLoS One 2012;7(9):e45567.

Zhang L, Smyrk TC, Young WF Jr, Stratakis CA, Carney JA. Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases. Am J Surg Pathol. 2010;34(1):53–64.

Barrisford GW, Singer EA, Rosner IL, Linehan WM, Bratslavsky G. Familial renal cancer: molecular genetics and surgical management. Int J Surg Oncol. 2011;2011:658767.

Baysal BE, Maher ER. 15 years of paraganglioma: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations. Endocr Relat Cancer. 2015;22(4):T71–82.

Benn DE, Robinson BG, Clifton-Bligh RJ. 15 years of paraganglioma: Clinical manifestations of paraganglioma syndromes types 1-5. Endocr Relat Cancer. 2015;22(4):T91–103.

Blakeley JO, Plotkin SR. Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis. Neuro Oncol. 2016;18(5):624–38.

Caban C, Khan N, Hasbani DM, Crino PB. Genetics of tuberous sclerosis complex: implications for clinical practice. Appl Clin Genet. 2016 Dec 21;10:1–8.

Canaff L, Vanbellinghen JF, Kanazawa I, Kwak H, Garfield N, Vautour L, Hendy GN. Menin missense mutants encoded by the MEN1 gene that are targeted to the proteasome: restoration of expression and activity by CHIP siRNA. J Clin Endocrinol Metab. 2012;97(2):E282–91.

Gammon A, Jasperson K, Champine M. Genetic basis of Cowden syndrome and its implications for clinical practice and risk management. Appl Clin Genet. 2016 Jul 13;9:83–92.

Helfferich J, Nijmeijer R, Brouwer OF, Boon M, Fock A, Hoving EW, Meijer L, den Dunnen WF, Bont ES de. Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas. Crit Rev Oncol Hematol. 2016;104:30–41.

Kingswood JC, Bissler JJ, Budde K, Hulbert J, Guay-Woodford L, Sampson JR, Sauter M, Cox J, Patel U, Elmslie F, Anderson C, Zonnenberg BA. Review of the Tuberous Sclerosis Renal Guidelines from the 2012 Consensus Conference: Current Data and Future Study. Nephron. 2016;134(2):51–8.

Kresak JL, Walsh M. Neurofibromatosis: A Review of NF1, NF2, and Schwannomatosis. J Pediatr Genet. 2016;5(2):98–104.

Lam HC, Nijmeh J, Henske EP. New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex. J Pathol. 2017;241(2):219–25.

Mori H1, Yao Y1, Learman BS1, Kurozumi K2, Ishida J2, Ramakrishnan SK1, Overmyer KA1, Xue X1, Cawthorn WP1,3, Reid MA1, Taylor M1, Ning X1,4, Shah YM1,5, MacDougald OA1,5. Induction of WNT11 by hypoxia and hypoxia-inducible factor-1α regulates cell proliferation, migration and invasion. Sci Rep. 2016 Feb 10;6:21520.

Ospina NS, Donegan D, Rodriguez-Gutierrez R, Al-Hilli Z, Young WF Jr. Assessing for multiple endocrine neoplasia type 1 in patients evaluated for Zollinger-Ellison Syndrome - clues to a safer diagnostic process. Am J Med. 2016 Dec 20.

Preez H du, Adams A, Richards P, Whitley S. Hyperparathyroidism jaw tumour syndrome: a pictoral review. Insights Imaging. 2016;7(6):793–800.

Romei C, Ciampi R, Elisei R. A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma. Nat Rev Endocrinol. 2016;12(4):192–202. https://www.ncbi.nlm.nih.gov/pubmed/26868437

Salvi PF, Lorenzon L, Caterino S, Antolino L, Antonelli MS, Balducci G. Gastrointestinal stromal tumors associated with neurofibromatosis 1: a single centre experience and systematic review of the literature including 252 cases. Int J Surg Oncol. 2013;2013:398570. http://www.ncbi.nlm.nih.gov/pubmed/24386562.

Schunemann V, Huntoon K, Lonser RR. Personalized medicine for nervous system manifestations of von Hippel-Lindau disease. Front Surg. 2016 Jun 30;3:39. https://www.ncbi.nlm.nih.gov/pubmed/?term=Schunemann%20V%5BAuthor%5D&cauthor=true&cauthor_uid=27446927, https://www.ncbi.nlm.nih.gov/pubmed/?term=Huntoon%20K%5BAuthor%5D&cauthor=true&cauthor_uid=27446927, https://www.ncbi.nlm.nih.gov/pubmed/?term=Lonser%20RR%5BAuthor%5D&cauthor=true&cauthor_uid=27446927, https://www.ncbi.nlm.nih.gov/pubmed/27446927.

Schödel J1, Grampp S2, Maher ER3, Moch H4, Ratcliffe PJ5, Russo P6, Mole DR5. Hypoxia, hypoxia-inducible transcription factors, and renal cancer. Eur Urol. 2016;69(4):646–57.

Stratakis CA. Carney complex: A familial lentiginosis predisposing to a variety of tumors. Rev Endocr Metab Disord. 2016;17(3):367–71.

Talarico C1, Dattilo V, D'Antona L, Menniti M, Bianco C, Ortuso F, Alcaro S, Schenone S, Perrotti N, Amato R. SGK1, the New Player in the Game of Resistance: Chemo-Radio Molecular Target and Strategy for Inhibition. Cell Physiol Biochem. 2016;39(5):1863–76.

Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567–610. https://www.ncbi.nlm.nih.gov/pubmed/25810047

Widemann BC, Acosta MT, Ammoun S, et al. CTF meeting 2012: translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. Am J Med Genet A. 2014;164A(3):563–78. http://www.ncbi.nlm.nih.gov/pubmed/24443315

Wilson TA, Rodgers S, Tanweer O, Agarwal P, Lieber BA, Agarwal N, McDowell M, Devinsky O, Weiner H, Harter DH. Tuberous Sclerosis Health Care Utilization Based on the National Inpatient Sample Database: A Review of 5655 Hospitalizations. World Neurosurg. 2016;91:97–105.

Wimmer K, Rosenbaum T, Messiaen L. Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1. Clin Genet. 2016 Oct 25.

Titel

Endocriene tumoren

Boek

Leerboek oncologie

Print ISBN: 978-90-368-0441-7

Elektronisch ISBN: 978-90-368-0442-4

https://doi.org/10.1007/978-90-368-0442-4

DOI

https://doi.org/10.1007/978-90-368-0442-4_30

Auteurs:

A. M. Pereira Arias
J. W. A. Smit
J. Kievit
E. Kapiteijn
P. T. A. M. Lips
C. J. Lips
H. R. Haak
E. P. M. van der Kleij-Corssmit
O. M. Dekkers
R. A. Feelders
N. R. Biermasz
W. de Herder
H. F. ten Kroode
Th. P. Links

Uitgeverij

Bohn Stafleu van Loghum

Volgnummer

Hoofdstuknummer

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Tip

Swipe om te navigeren naar een ander hoofdstuk

Samenvatting

Log in om toegang te krijgen

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Academy Geneeskunde UMCU 2018-2019

BSL Academy Geneeskunde Radboud 2018-2019

BSL Academy Oncologische Zorg HU 2018-2019

BSL - Leerboek oncologie

BSL Academy Oncologische Zorg HU 2019-2020

BSL Academy Geneeskunde Radboud Universiteit 2019-2020

BSL Academy Geneeskunde UMC Utrecht 2019-2020

BSL Academy Radboud Universiteit 2020-2021

BSL Academy Geneeskunde UMC Utrecht 2020-2023

BSL Academy Oncologische Zorg HU 2020-2021